Influence of bioavailability on blood level of mizoribine in kidney transplant recipients

Transplant Proc. 1996 Jun;28(3):1321-3.

Authors

H Ihara¹, D Shinkuma, M Kubo, I Miyamoto, M Nojima, H Koike, H Yabumoto, F Ikoma

Affiliation

¹ Departments of Urology, Hyogo College of Medicine, Japan.

PMID: 8658677

No abstract available

MeSH terms

Biological Availability
Chromatography, High Pressure Liquid
Creatinine / metabolism
Cyclosporine / therapeutic use
Drug Therapy, Combination
Humans
Immunosuppressive Agents / blood*
Immunosuppressive Agents / pharmacokinetics
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / immunology*
Methylprednisolone / therapeutic use
Regression Analysis
Ribonucleosides / blood*
Ribonucleosides / pharmacokinetics
Ribonucleosides / therapeutic use
Sensitivity and Specificity

Substances

Immunosuppressive Agents
Ribonucleosides
mizoribine
Cyclosporine
Creatinine
Methylprednisolone